Stockreport

Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa

Abeona Therapeutics Inc.  (ABEO) 
Last abeona therapeutics inc. earnings: 3/16 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.abeonatherapeutics.com
PDF Company to provide additional transport stability data points in response to FDA Clinical Hold LetterCMC clearance for VIITALâ„¢ trial anticipated in Q4 2019Investor confe [Read more]